PL337201A1 - Composition containing 5-[4-[2- ( n-methyl-n-2-pyridyl) amino ethoxy] benzyl] triazinolydino-2,4-dione - Google Patents

Composition containing 5-[4-[2- ( n-methyl-n-2-pyridyl) amino ethoxy] benzyl] triazinolydino-2,4-dione

Info

Publication number: PL337201A1
Authority: PL; Poland
Prior art keywords: triazinolydino; dione; pyridyl; benzyl; methyl
Prior art date: 1997-06-05

Application number

PL98337201A

Inventor

Jai Patel

Hamish Ross

Jeffrey Roger Granett

Robin Price

Paul Nigel Wray

Original Assignee

Smithkline Beecham Plc

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-06-05

Filing date

1998-06-02

Publication date

2000-08-14

1997-06-18 Priority claimed from GBGB9712851.6A external-priority patent/GB9712851D0/en

1998-06-02 Application filed by Smithkline Beecham Plc, Smithkline Beecham Corp filed Critical Smithkline Beecham Plc

2000-08-14 Publication of PL337201A1 publication Critical patent/PL337201A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

Health & Medical Sciences (AREA)
Diabetes (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Obesity (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

PL98337201A 1997-06-05 1998-06-02 Composition containing 5-[4-[2- ( n-methyl-n-2-pyridyl) amino ethoxy] benzyl] triazinolydino-2,4-dione PL337201A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9711683.4A GB9711683D0 (en)	1997-06-05	1997-06-05	Composition
GBGB9712851.6A GB9712851D0 (en)	1997-06-18	1997-06-18	Composition

Publications (1)

Publication Number	Publication Date
PL337201A1 true PL337201A1 (en)	2000-08-14

Family

ID=26311662

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL98337201A PL337201A1 (en)	1997-06-05	1998-06-02	Composition containing 5-[4-[2- ( n-methyl-n-2-pyridyl) amino ethoxy] benzyl] triazinolydino-2,4-dione

Country Status (29)

Country	Link
EP (1)	EP0998284A1 (en)
JP (1)	JP2001521553A (en)
KR (1)	KR20010013410A (en)
CN (3)	CN1112926C (en)
AP (1)	AP1214A (en)
AR (2)	AR015120A1 (en)
AU (1)	AU8215098A (en)
BG (1)	BG104048A (en)
BR (1)	BR9810405A (en)
CA (2)	CA2333352A1 (en)
CO (1)	CO4940400A1 (en)
DZ (1)	DZ2510A1 (en)
EA (1)	EA002384B1 (en)
GB (1)	GB9711683D0 (en)
HU (1)	HUP0004070A3 (en)
ID (1)	ID24264A (en)
IL (1)	IL133074A0 (en)
MX (1)	MXPA99011322A (en)
NO (2)	NO995938L (en)
NZ (2)	NZ523725A (en)
OA (1)	OA11306A (en)
PE (1)	PE78899A1 (en)
PL (1)	PL337201A1 (en)
SK (1)	SK164899A3 (en)
TR (2)	TR199902963T2 (en)
TW (1)	TW570797B (en)
UY (1)	UY25032A1 (en)
WO (1)	WO1998055122A1 (en)
ZA (2)	ZA984826B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7045519B2 (en)	1998-06-19	2006-05-16	Chiron Corporation	Inhibitors of glycogen synthase kinase 3
US20040248945A1 (en)	1999-04-23	2004-12-09	Smithkline Beecham P.L.C.	Thiazolidinedione derivative and its use as antidiabetic
BR0009934A (en)	1999-04-23	2002-06-04	Smithkline Beecham Plc	Pharmaceutical
ATE246191T1 (en) *	1999-04-23	2003-08-15	Smithkline Beecham Plc	POLYMORPHOUS OF 5-(4-(2-(N-METHYL-N-(2-PYRDYL)AMINO)ETHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE MALEIC ACID SALT
GB0021978D0 (en)	2000-09-07	2000-10-25	Smithkline Beecham Plc	Novel pharmaceutical
GB0127805D0 (en) *	2001-11-20	2002-01-09	Smithkline Beecham Plc	Pharmaceutical composition
GB0129871D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
GB0129876D0 (en) *	2001-12-13	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
WO2003050112A1 (en) *	2001-12-13	2003-06-19	Smithkline Beecham Plc	Toluenesulfonate hydrates of a thiazolidinedione derivative
GB0130509D0 (en) *	2001-12-20	2002-02-06	Smithkline Beecham Plc	Novel pharmaceutical
ES2294980T1 (en) *	2006-05-09	2008-04-16	Teva Pharmaceutical Industries Ltd.	ACID 2-N- (5 - ((4- (2- (METHYL-2-PYRIDINYLAMINE) ETHOXY) PHENYL) METHYL) -2,4-THIAZOLIDINDIONA) -BUTANODIOIC, PREPARATION PROCEDURES AND COMPOSITIONS WITH ROSIGLITAZONA MALEATE.
US7435741B2 (en)	2006-05-09	2008-10-14	Teva Pharmaceutical Industries, Ltd.	2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2015008234A1 (en) *	2013-07-17	2015-01-22	Glenmark Pharmaceuticals S.A.	Bicyclic heterocyclic compounds as ror gamma modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0306228B1 (en) *	1987-09-04	1999-11-17	Beecham Group Plc	Substituted thiazolidinedione derivatives
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
WO1995021608A1 (en) *	1994-02-10	1995-08-17	Smithkline Beecham Plc	Use of insulin sensitisers for treating renal diseases
KR19990036290A (en) *	1995-08-10	1999-05-25	로즈 암스트롱	Reduction of Exogenous Insulin Dosage in Non-insulin-Dependent Diabetic Patients
WO1997018811A1 (en) *	1995-11-17	1997-05-29	Warner-Lambert Company	A method of treating myotonic dystrophy
NZ314406A (en) *	1996-03-18	2000-12-22	Sankyo Co	Treatment or prophylaxis of pancreatitis with a medicament containing an insulin sensitiser including oxazoles and thiazoles
EP0921798A1 (en) *	1996-07-12	1999-06-16	Smithkline Beecham Plc	Novel treatment of leptine resistance

1997
- 1997-06-05 GB GBGB9711683.4A patent/GB9711683D0/en active Pending
1998
- 1998-06-02 AP APAP/P/1999/001696A patent/AP1214A/en active
- 1998-06-02 PL PL98337201A patent/PL337201A1/en unknown
- 1998-06-02 WO PCT/EP1998/003478 patent/WO1998055122A1/en not_active Ceased
- 1998-06-02 IL IL13307498A patent/IL133074A0/en unknown
- 1998-06-02 SK SK1648-99A patent/SK164899A3/en unknown
- 1998-06-02 AU AU82150/98A patent/AU8215098A/en not_active Abandoned
- 1998-06-02 EA EA199901116A patent/EA002384B1/en not_active IP Right Cessation
- 1998-06-02 TR TR1999/02963T patent/TR199902963T2/en unknown
- 1998-06-02 KR KR19997011411A patent/KR20010013410A/en not_active Ceased
- 1998-06-02 JP JP50158799A patent/JP2001521553A/en not_active Ceased
- 1998-06-02 BR BR9810405-5A patent/BR9810405A/en not_active IP Right Cessation
- 1998-06-02 TR TR2000/02790T patent/TR200002790T2/en unknown
- 1998-06-02 HU HU0004070A patent/HUP0004070A3/en unknown
- 1998-06-02 ID IDW991520A patent/ID24264A/en unknown
- 1998-06-02 MX MXPA99011322A patent/MXPA99011322A/en unknown
- 1998-06-02 CA CA002333352A patent/CA2333352A1/en not_active Abandoned
- 1998-06-02 NZ NZ523725A patent/NZ523725A/en unknown
- 1998-06-02 CN CN98805686A patent/CN1112926C/en not_active Expired - Lifetime
- 1998-06-02 EP EP98932144A patent/EP0998284A1/en not_active Withdrawn
- 1998-06-02 CA CA002292629A patent/CA2292629C/en not_active Expired - Fee Related
- 1998-06-02 CN CNA2003101199090A patent/CN1526391A/en active Pending
- 1998-06-03 DZ DZ980120A patent/DZ2510A1/en active
- 1998-06-04 AR ARP980102650A patent/AR015120A1/en not_active Application Discontinuation
- 1998-06-04 ZA ZA9804826A patent/ZA984826B/en unknown
- 1998-06-04 ZA ZA9811572A patent/ZA9811572B/en unknown
- 1998-06-04 UY UY25032A patent/UY25032A1/en not_active IP Right Cessation
- 1998-06-04 AR ARP980102649A patent/AR008198A1/en not_active Application Discontinuation
- 1998-06-04 CO CO98031614A patent/CO4940400A1/en unknown
- 1998-06-05 PE PE1998000466A patent/PE78899A1/en not_active Application Discontinuation
- 1998-10-23 TW TW087117536A patent/TW570797B/en not_active IP Right Cessation
1999
- 1999-12-02 OA OA9900267A patent/OA11306A/en unknown
- 1999-12-03 NO NO995938A patent/NO995938L/en not_active Application Discontinuation
- 1999-12-27 BG BG104048A patent/BG104048A/en unknown
2001
- 2001-09-03 NZ NZ513922A patent/NZ513922A/en unknown
2002
- 2002-11-05 CN CN02149972A patent/CN1430959A/en active Pending
2004
- 2004-02-20 NO NO20040738A patent/NO20040738L/en not_active Application Discontinuation

Also Published As

Publication number	Publication date
NO20040738L (en)	2000-02-02
CO4940400A1 (en)	2000-07-24
OA11306A (en)	2003-10-22
CA2292629A1 (en)	1998-12-10
PE78899A1 (en)	1999-10-22
AR015120A1 (en)	2001-04-18
BG104048A (en)	2000-07-31
NZ513922A (en)	2001-09-28
KR20010013410A (en)	2001-02-26
HUP0004070A3 (en)	2002-03-28
TW570797B (en)	2004-01-11
CN1430959A (en)	2003-07-23
ZA984826B (en)	1999-08-03
AP9901696A0 (en)	1999-12-31
CA2292629C (en)	2004-01-06
IL133074A0 (en)	2001-03-19
HUP0004070A2 (en)	2002-02-28
NZ523725A (en)	2004-09-24
AR008198A1 (en)	1999-12-29
EA002384B1 (en)	2002-04-25
SK164899A3 (en)	2000-11-07
CN1526391A (en)	2004-09-08
CA2333352A1 (en)	1998-12-10
AU8215098A (en)	1998-12-21
TR200002790T2 (en)	2001-11-21
TR199902963T2 (en)	2000-02-21
NO995938D0 (en)	1999-12-03
ID24264A (en)	2000-07-13
CN1259050A (en)	2000-07-05
WO1998055122A1 (en)	1998-12-10
UY25032A1 (en)	1998-11-26
GB9711683D0 (en)	1997-08-06
EP0998284A1 (en)	2000-05-10
CN1112926C (en)	2003-07-02
BR9810405A (en)	2000-08-29
JP2001521553A (en)	2001-11-06
ZA9811572B (en)	1999-07-22
EA199901116A1 (en)	2000-06-26
AP1214A (en)	2003-10-08
NO995938L (en)	2000-02-02
DZ2510A1 (en)	2003-01-25
MXPA99011322A (en)	2004-12-02

Publication	Publication Date	Title
WO2000017190A3 (en)	2000-10-26	Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
PL337201A1 (en)	2000-08-14	Composition containing 5-[4-[2- ( n-methyl-n-2-pyridyl) amino ethoxy] benzyl] triazinolydino-2,4-dione
AU8441798A (en)	1999-02-10	Tricyclically substituted oxazolidinones
PL341146A1 (en)	2001-03-26	Maleic 5-[4-[2-(n-methyl-n-(2-pyridil)amino)ethoxy]benzyl]thiazolydin-2,4-dione salt hydrate as a pharmacological agent
IL146111A0 (en)	2002-07-25	5-[4-[2-(n-methyl-n-(2-pyridyl) amino)ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt
AU7907498A (en)	1999-01-19	Novel heterocyclic compounds
PL341147A1 (en)	2001-03-26	Maleic 5-[4-[2[(n-methyl-n-(2-pyridil)amino)ethoxy]benzyl}thiazolydin-2,4-dione salt hydrate
NO2009002I1 (en)	2009-03-02	5- {4- [2- (N-methyl-N- (2-pyridyl) amino) ethoxy] benzyl} thiazolidine-2,4-dionmaleat (salts / solvates) + glimepiride
AU7907298A (en)	1999-01-19	Novel heterocyclic compounds
ZA984795B (en)	1999-01-04	New thiazolidinedione oxazolidinedione and oxadiazolidinedione derivatives
ZA972973B (en)	1997-11-03	Substituted [2-(1-piperazinyl)ethoxy]methyl compounds.
AU2231397A (en)	1997-09-22	Thiazolidine-2,4-dione derivatives
AU6291098A (en)	1998-09-29	Novel heterocyclic compounds
AU4167099A (en)	2000-01-05	Heterocyclic compounds as hypoglycemic agents
IL125453A0 (en)	1999-03-12	4-(Benzo-1,3-dioxylyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
HUP0003710A3 (en)	2002-01-28	2-{3-[4-(2-t-butyl-6-trifluoromethylpyridin-4-yl)piperazin-1-yl]propylmercapto}pyrimidin-4-ol-fumarate and pharmaceutical composition containing this compound
IL160144A0 (en)	2004-06-20	Composition comprising 5-[4-[2-(n-methyl-n-2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione
MXPA03001956A (en)	2003-06-24	The hydrochloride salt of 5-[4-[2-(n -methyl-n-(2 -pyridyl) amino) ethoxy] benzyl] thiazolidine-2, 4-dione.
HU9802874D0 (en)	1999-02-01	Process for making 2-(methylthio)-5-(trifluoromethyl)-1,3,4-thiadiazole using methyldithiocarbazinate
AUPO622597A0 (en)	1997-05-08	New heterocyclic compounds
PL354991A1 (en)	2004-03-22	Sodium 2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionate and use thereof as endothelin antagonist
AU8440498A (en)	1999-02-08	5-(3-phenyl-3-oxo-propyl)-1h-tetrazole derivatives
AU5437398A (en)	1999-03-01	Improved hand-held container for predissolving detergent composition
AUPO527597A0 (en)	1997-03-20	Novel heterocyclic compounds
HK1028191A (en)	2001-02-09	Composition comprising 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazo lidine-2,4-dione